Navigation Links
Free 2D/3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging
Date:11/3/2009

REDMOND, Wash., Nov. 3 /PRNewswire/ -- Medical software company FiatLux Imaging, Inc., located in Redmond, WA, announces the availability of FiatLux Visualize(TM) Free, advanced 2D/3D visualization software for CT and MRI imaging data. The free software is available for any healthcare professional via download from www.FiatLuxImaging.com. There is no charge for download or use.

"There is tremendous unrealized potential in medical imaging data," stated Quentin Dewolf, CEO of FiatLux Imaging.

"CT and MRI scanners generate huge amounts of data every day, yet the vast majority of that data is never seen outside of the radiology suite. If it were, we believe referring physicians could make better decisions, patients could gain insight into their conditions, and the expense and inconvenience of duplicate scans could be avoided.

We deliver advanced visualization to any healthcare professional, not just the small number of radiologists using expensive software on high-end workstations."

FiatLux Visualize Free is the only free advanced visualization software for CT and MRI imaging data that runs on virtually any modern Windows PC/laptop/notebook/tablet - including Windows 7 - and is cleared by the FDA for clinical use in the United States. FiatLux Visualize Free is a fully-featured 2D/3D visualization application - not a demo - for any healthcare professional needing an easy-to-use means of reformatting and viewing DICOM-compatible imaging data.

The software is useful for any healthcare professional, including specialists such as surgeons and cardiologists, primary care physicians, radiologists and radiologic technologists, physician's assistants, and clinical nurse specialists. Medical students and residents will find FiatLux Visualize Free invaluable for studying anatomy, identifying pathology, and reviewing cases.

Typical uses of FiatLux Visualize Free include an easy-to-use, 2D/3D viewer of images on CD or DVD, radiologist report verification, patient education, and procedure planning.

According to Dewolf, "We are offering this software for free because we believe that democratizing medical imaging data is important in the context of healthcare reform and because it is the fastest way to build a user community. We plan to add valuable features based on the input of those users. Many features will remain free and some will be available for a fee, referred to as the 'freemium' approach."

FiatLux Imaging, founded in 2007, is dedicated to transforming medical imaging data into insight...for anyone. www.FiatLuxImaging.com

    Contact:
    Tom Sanko
    FiatLux Imaging, Inc.
    Tom.Sanko@FiatLuxImaging.com
    425.605.0902
    www.FiatLuxImaging.com

SOURCE FiatLux Imaging, Inc.


'/>"/>
SOURCE FiatLux Imaging, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), ... company,s second affiliate in Latin America . ... ... Colombia ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
Breaking Medicine News(10 mins):